![]() |
市場調查報告書
商品編碼
1492681
體外循環系統市場:按產品類型、應用和最終用戶分類 - 全球預測 2024-2030Extracorporeal Circulation System Market by Product (Blood Filters, Cannulae, Heart-Lung Machines), Type (Bench Top, Portable), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年體外循環系統市場規模為13.5億美元,預計2024年將達14.6億美元,2030年將達23.4億美元,複合年成長率為8.11%。
體外循環系統(ECS)是醫療設備,用於暫時支持和取代患者的自然循環功能。它接管心臟和肺部的作用,為體外患者的血液提供氧氣,維持全身的血液循環。這確保了重要器官能夠持續獲得富氧血液的供應,即使心臟在手術過程中無法運作。該技術有助於減輕手術期間心臟的壓力,並為外科醫生執行複雜手術提供受控環境。全球心血管疾病的增加導致對心血管手術的需求增加,增加了對 ECS 的需求。此外,醫療基礎設施的擴張和醫療設施的投資也對市場擴張做出了重大貢獻。然而,ECS 設備的高昂成本和相關營運費用可能會讓一些醫療機構望而卻步,尤其是在低度開發和發展中地區。操作 ECS 的複雜性需要訓練有素的專業人員,這在缺乏醫學教育和培訓基礎設施的地區可能會成為障礙。此外,ECS 技術的創新可提高外科手術的安全性和有效性,也是市場成長的主要機會。最大限度地減少併發症並改善患者治療效果的設計和功能改進尤其具有影響力。
主要市場統計 | |
---|---|
基準年[2023] | 13.5億美元 |
預測年份 [2024] | 14.6億美元 |
預測年份 [2030] | 23.4億美元 |
複合年成長率(%) | 8.11% |
區域洞察
全球體外循環系統市場以美洲為主,其中美國憑藉其強大的醫療體系、高昂的醫療成本以及大型醫療設備公司的強大影響力而處於領先地位。加拿大是一個由政府資助的醫療保健系統和對醫學研究的承諾所驅動的市場。該地區的重點是技術先進、高效和安全的醫療解決方案。歐洲是體外循環系統的強大市場,其特點是廣泛的研發活動,特別是在歐盟國家。該市場受益於完善的醫療保健體系和嚴格的監管標準,可確保高品質的醫療設備。在中東,醫療保健投資的增加和尖端醫療技術的引入正在推動市場成長。目前非洲市場規模較小,但由於醫療基礎設施改善和國際投資,逐漸成長。在醫療保健成本上升、心血管疾病盛行率增加以及醫療保健基礎設施加強的推動下,亞太地區的體外循環系統市場正在顯著成長。中國因其龐大的患者人數和不斷成長的醫療旅遊業而在該地區處於領先地位。在日本,技術進步和強大的政府醫療保健政策正在推動市場發展。在印度,由於人們對先進治療方法的認知不斷增強以及私營部門對醫療保健的投資增加,市場正在擴大。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在體外循環系統市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對體外循環系統市場供應商的現狀進行深入而詳細的評估。對供應商貢獻的徹底比較和分析可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該細分市場競爭力的寶貴見解,包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以更好地參與市場競爭。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對體外循環系統市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[184 Pages Report] The Extracorporeal Circulation System Market size was estimated at USD 1.35 billion in 2023 and expected to reach USD 1.46 billion in 2024, at a CAGR 8.11% to reach USD 2.34 billion by 2030.
An extracorporeal circulation system is a medical device used primarily in surgeries to support and replace the patient's natural circulatory function temporarily. The device takes over the role of the heart and lungs by oxygenating the blood outside the patient's body and maintaining the circulation of blood throughout the body. This ensures that vital organs receive a continuous supply of oxygen-rich blood despite the heart not functioning during the surgery. This technology helps reduce the strain on the heart during surgery and offers a controlled environment for the surgeon to perform complex procedures. Rising incidences of cardiovascular diseases globally lead to higher demand for cardiac surgeries, thereby driving the need for ECS. Additionally, expansion in healthcare infrastructure and investments in medical facilities contribute significantly to market expansion. However, the high cost of ECS equipment and the operation expenditure involved can be prohibitive for some institutions, particularly in underdeveloped and developing regions. The complexity of operating ECS necessitates highly trained professionals, which might be a barrier in regions lacking in medical education and training infrastructure. Furthermore, innovation in ECS technology, which increases the safety and efficacy of surgical procedures, is a significant opportunity for market growth. Improved designs and functionalities that minimize complications and enhance patient outcomes are particularly influential.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.35 billion |
Estimated Year [2024] | USD 1.46 billion |
Forecast Year [2030] | USD 2.34 billion |
CAGR (%) | 8.11% |
Regional Insights
The Americas dominate the global extracorporeal circulation system market, with the United States leading due to its robust healthcare system, high healthcare spending, and strong presence of leading medical device companies. Canada's market is driven by its government-funded healthcare system and initiatives in medical research. The region shows a high emphasis on technologically advanced, efficient, and safe healthcare solutions. Europe is a strong market for extracorporeal circulation systems, characterized by extensive research and development activities, particularly in EU countries. The market benefits from well-established healthcare systems and stringent regulatory standards ensuring high-quality medical devices. In the Middle East, the market growth is fueled by rising healthcare investment and the adoption of cutting-edge medical technologies. Africa is currently a smaller market but is gradually growing due to improved healthcare infrastructure and international investment. The APAC region is noticing significant growth in the extracorporeal circulation systems market, driven by increasing healthcare expenses, growing prevalence of cardiovascular diseases, and enhanced healthcare infrastructure. China is leading the region due to its large patient population and growing medical tourism. In Japan, advancements in technology and strong government healthcare policies are propelling the market. India's market is expanding due to rising awareness about advanced treatment methods and increasing private sector investments in healthcare.
Market Insights
The market dynamics represent an ever-changing landscape of the Extracorporeal Circulation System Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Extracorporeal Circulation System Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Extracorporeal Circulation System Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
FDA Approves LivaNova's LifeSPARC System for ECMO Use
LivaNova PLC, a leader in medical technology, announced that its LifeSPARC Advanced Circulatory Support system has received FDA 510(k) clearance for use in extracorporeal membrane oxygenation (ECMO). The clearance comes after successful integration of real-world evidence, including data from the COVID-19 pandemic. The LifeSPARC system is designed to enhance patient support during severe cardiac and respiratory failure. This approval marks a significant step in its deployment across healthcare settings. [Published On: 2022-11-17]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Extracorporeal Circulation System Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Extracorporeal Circulation System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK, Boston Scientific, CardioFocus, Edwards Lifesciences, EUROSETS S.r.l., LivaNova PLC, Maquet Holding B.V. & Co. KG by Getinge Group, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, OriGen Biomedical, Inc., Philips Healthcare, Siemens Healthineers, Terumo Corporation, and XENIOS AG by Fresenius Medical Care AG & Co. KGaA.
Market Segmentation & Coverage